|
FEM1C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.99840144432528E-15 |
| Normal-vs-Stage2 |
1.170860E-04 |
| Normal-vs-Stage3 |
1.3178000002334E-07 |
| Normal-vs-Stage4 |
2.010900E-04 |
| Stage1-vs-Stage2 |
6.583600E-01 |
| Stage1-vs-Stage3 |
8.449600E-01 |
| Stage1-vs-Stage4 |
3.202200E-01 |
| Stage2-vs-Stage3 |
5.907000E-01 |
| Stage2-vs-Stage4 |
3.115800E-01 |
| Stage3-vs-Stage4 |
5.207600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.378060E-03 |
| Normal-vs-Asian |
1.161010E-01 |
| Caucasian-vs-AfricanAmerican |
2.356900E-04 |
| Caucasian-vs-Asian |
9.276800E-01 |
| AfricanAmerican-vs-Asian |
3.484400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.1863400806742E-14 |
| Normal-vs-Female |
1.92001969878675E-12 |
| Male-vs-Female |
9.225800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.019770E-02 |
| Normal-vs-Age(41-60Yrs) |
4.49196235763338E-12 |
| Normal-vs-Age(61-80Yrs) |
3.57602836231763E-13 |
| Normal-vs-Age(81-100Yrs) |
6.719200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.996400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.767800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.355000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.998600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.711800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.928600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.969880E-02 |
| Normal-vs-Grade 2 |
1.78157488761599E-12 |
| Normal-vs-Grade 3 |
2.60620414138657E-11 |
| Normal-vs-Grade 4 |
5.90329999999861E-05 |
| Grade 1-vs-Grade 2 |
9.808400E-01 |
| Grade 1-vs-Grade 3 |
8.865800E-01 |
| Grade 1-vs-Grade 4 |
8.117800E-01 |
| Grade 2-vs-Grade 3 |
7.056800E-01 |
| Grade 2-vs-Grade 4 |
5.628800E-01 |
| Grade 3-vs-Grade 4 |
4.529000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.22044604925031E-16 |
| Normal-vs-ccB subtype |
1.66000002632671E-09 |
| ccA subtype-vs-ccB subtype |
1.414770E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.6340709047854E-13 |
| Normal-vs-N1 |
2.871800E-01 |
| N0-vs-N1 |
1.594990E-01 |
|
|
